This is the first approval of a prescription transdermal dosage Form in the European markets from this facility
The topical fluralaner solution is cleared for the prevention and treatment of new world screwworm infestation
Here's a development that aims to keep your blood pressure in check. Literally!
The deal aims to address long-standing imbalances in pharmaceutical trade while boosting investment and innovation on both sides of the Atlantic
Patients can now get the starting 2.5 mg dose for $299 per month
GLP-1 therapies are among the fastest-growing drug classes worldwide, projected to drive a $95 billion obesity market by 2030
Renalyx will continue operating as an independent unit within the group
AVT03 is a biosimilar of Amgen's Prolia (denosumab 60 mg/mL) and Xgeva (denosumab 70 mg/mL), which are used to treat various bone conditions
The formulation is backed by over 80 clinical trials and 200 scientific publications
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
Subscribe To Our Newsletter & Stay Updated
